432 filings
Page 4 of 22
6-K
qvuj1m
24 Jul 19
Update on its Oxycodone ER New Drug Application
5:13pm
6-K
7iurpe2
10 Jul 19
Primary Document
5:08pm
6-K
gftwln
8 Jul 19
Primary Document
5:18pm
25-NSE
pm0x7
3 Jun 19
Exchange delisting
9:59am
6-K
b40krckub nvarl
30 May 19
Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada
8:51am
6-K
0olbc04s
29 May 19
Intellipharmaceutics Reports Director Election Results
5:07pm
424B3
i3hu8
29 May 19
Prospectus supplement
3:18pm
424B3
vca9jqxem8ny u97lxg
29 May 19
Prospectus supplement
3:13pm
6-K
r5sl7cguyix ir8
29 May 19
Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
9:38am
6-K
9ebw28c99e
28 May 19
Annual & Special Meeting of Shareholders
4:41pm
424B3
0rp20fp
10 May 19
Prospectus supplement
3:26pm
424B3
fsrdu9gbn912t
10 May 19
Prospectus supplement
3:18pm
6-K
p4v rj73x4d0nqsbatos
10 May 19
Primary Document
1:07pm
6-K
ntnxde0c0rc0wo1
8 May 19
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing
12:00am
424B3
snzet88
26 Apr 19
Prospectus supplement
12:13pm
424B3
zaa363sjjcyvyrmy vl
26 Apr 19
Prospectus supplement
12:10pm
6-K
vy69i2u 8t7q
26 Apr 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
12:00am
424B3
dhpvtt1zr eq
17 Apr 19
Prospectus supplement
10:49am
424B3
jhm0aecym5h8
17 Apr 19
Prospectus supplement
10:46am
6-K
nxtzobkjp47x3e5h9ue9
15 Apr 19
Primary Document
4:25pm